Lipid profiling following intake of the omega 3 fatty acid DHA identifies the peroxidized metabolites F4-neuroprostanes as the best predictors of atherosclerosis prevention

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Gladine, Cécile ^a   Newman, John W ^b,c   Durand, Thierry ^d   Pedersen, Theresa L ^b   Galano, Jean Marie ^d   Demougeot, Céline ^e   Berdeaux, Olivier ^f,g   Pujos Guillot, Estelle ^a,h   Mazur, Andrzej ^a   Comte, Blandine ^a  

^a CRNH AUVERGNE   (France)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIV MONTPELLIER   (France)

^e France   (France)

^f CNRS   (France)

^g CENTRE DES SCIENCES DU GOÛT ET DE L ALIMENTATION   (France)

^h INRA and University of Auvergne   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CERVONIC ACID; DOCOSAHEXAENOIC ACID; F4 NEUROPROSTANE; ICOSAPENTAENOIC ACID; NEUROPROSTANE; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATIONAL STUDY; DIETARY INTAKE; DOSE RESPONSE; DRUG MECHANISM; FAT INTAKE; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LIPID ANALYSIS; LIVER LEVEL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PREDICTIVE VALUE; PREDICTOR VARIABLE;

ANALYSIS OF VARIANCE; ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CHROMATOGRAPHY, LIQUID; CLUSTER ANALYSIS; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, UNSATURATED; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEART RATE; LIPID METABOLISM; LIVER; MICE; MICE, KNOCKOUT; NEUROPROSTANES; RECEPTORS, LDL; TANDEM MASS SPECTROMETRY;

EID: 84895873385     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089393     Document Type: Article

References (52)

1. Miles EA, Calder PC (2012) Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Br J Nutr 107 Suppl 2: S171-184.
2. Calder PC (2012) The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol Nutr Food Res 56: 1073-1080.
3. Brown AL, Zhu X, Rong S, Shewale S, Seo J, et al. (2012) Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions. Arterioscler Thromb Vasc Biol 32: 2122-2130.
4. Erkkila AT, Lichtenstein AH, Mozaffarian D, Herrington DM (2004) Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am J Clin Nutr 80: 626-632. (Pubitemid 41115527)
5. De Caterina R, Zampolli A (2001) n-3 fatty acids: antiatherosclerotic effects. Lipids 36 Suppl: S69-78. (Pubitemid 34106212)
6. Serhan CN, Krishnamoorthy S, Recchiuti A, Chiang N (2011) Novel anti-inflammatory-pro-resolving mediators and their receptors. Curr Top Med Chem 11: 629-647.
7. Shearer GC, Harris WS, Pedersen TL, Newman JW (2010) Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters. J Lipid Res 51: 2074-2081.
8. Cosgrove JP, Church DF, Pryor WA (1987) The kinetics of the autoxidation of polyunsaturated fatty acids. Lipids 22: 299-304.
9. Jahn U, Galano J, Durand T (2008) Beyond prostaglandins - Chemistry and biology of cyclic oxygenated metabolites fromed by free-radical pathways from polyunsaturated fatty acids. Angew Chem Int Ed 47: 5894-5955.
10. Roberts LJ 2nd, Montine TJ, Markesbery WR, Tapper AR, Hardy P, et al. (1998) Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem 273: 13605-13612. (Pubitemid 28268404)
11. Milne GL, Yin H, Hardy KD, Davies SS, Roberts LJ 2nd (2011) Isoprostane generation and function. Chem Rev 111: 5973-5996.
12. Stocker R, Keaney JF Jr (2005) New insights on oxidative stress in the artery wall. J Thromb Haemost 3: 1825-1834. (Pubitemid 41716569)
13. Simopoulos AP, Leaf A, Salem N Jr (2000) Workshop statement on the essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 63: 119-121.
14. Zampolli A, Bysted A, Leth T, Mortensen A, De Caterina R, et al. (2006) Contrasting effect of fish oil supplementation on the development of atherosclerosis in murine models. Atherosclerosis 184: 78-85. (Pubitemid 41721072)
15. Nicoletti A, Kaveri S, Caligiuri G, Bariety J, Hansson GK (1998) Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. J Clin Invest 102: 910-918. (Pubitemid 28419236)
16. Mazur A, Remesy C, Gueux E, Levrat MA, Demigne C (1990) Effects of diets rich in fermentable carbohydrates on plasma lipoprotein levels and on lipoprotein catabolism in rats. J Nutr 120: 1037-1045. (Pubitemid 20306065)
17. Smedes F (1999) Determination of total lipid using non-chlorinated solvents. Analyst 124: 1711-1718.
18. Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, et al. (2011) The human serum metabolome. PLoS One 6: e16957.
19. Newman JW, Watanabe T, Hammock BD (2002) The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS. J Lipid Res 43: 1563-1578.
20. Newman JW, Kaysen GA, Hammock BD, Shearer GC (2007) Proteinuria increases oxylipid concentrations in VLDL and HDL but not LDL particles in the rat. J Lipid Res 48: 1792-1800. (Pubitemid 47311996)
21. Shearer GC, Newman JW (2008) Lipoprotein lipase releases esterified oxylipins from very low-density lipoproteins. Prostaglandins Leukot Essent Fatty Acids 79: 215-222.
22. Perera SK, Fedor LR (1979) Acid-catalyzed and base-catalyzed dehydration of prostaglandin-e2 to prostaglandin-a2 and general-base-catalyzed isomerization of prostaglandin-a2 to prostaglandin-b2. Journal of the American Chemical Society 101: 7390-7393. (Pubitemid 10169547)
23. Gladine C, Roy NC, Rigaudiere JP, Laillet B, Da Silva G, et al. (2011) Increasing intake of long-chain n-3 PUFA enhances lipoperoxidation and modulates hepatic gene expression in a dose-dependent manner. Br J Nutr: 1-20.
24. Musiek ES, Cha JK, Yin H, Zackert WE, Terry ES, et al. (2004) Quantification of F-ring isoprostane-like compounds (F4-neuroprostanes) derived from docosahexaenoic acid in vivo in humans by a stable isotope dilution mass spectrometric assay. J Chromatogr B Analyt Technol Biomed Life Sci 799: 95-102. (Pubitemid 37500867)
25. Zhao Z, Hjelm NM, Lam CW, Ho CS (2001) One-step solid-phase extraction procedure for F(2)-isoprostanes. Clin Chem 47: 1306-1308. (Pubitemid 32579122)
26. Oger C, Brinkmann Y, Bouazzaoui S, Durand T, Galano JM (2008) Stereocontrolled access to isoprostanes via a bicyclo[3.3.0]octene framework. Org Lett 10: 5087-5090.
27. Oger C, Bultel-Ponce V, Guy A, Balas L, Rossi JC, et al. (2010) The handy use of Brown's P2-Ni catalyst for a skipped diyne deuteration: application to the synthesis of a [D4]-labeled F4t-neuroprostane. Chemistry 16: 13976-13980.
28. van den Berg RA, Hoefsloot HC, Westerhuis JA, Smilde AK, van der Werf MJ (2006) Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 7: 142.
29. Qu L, Li L, Zhang Y, Hu J (2009) PPCA-Based Missing Data Imputation for Traffic Flow Volume: A Systematical Approach. IEEE Transactions on intelligent transportation systems 10: 512-521.
30. Wang C, Wang W (2006) Links between PPCA and subspace methods for complete Gaussian density estimation. IEEE Trans Neural Netw 17: 789-792.
31. Box GEP, Cox DR (1964) An analysis of transformations. Journal of the Royal Statisistical Society 26: 211-252.
32. Grapov D, Newman JW (2012) imDEV: a Graphical User Interface to R Multivariate Analysis Tools in Microsoft Excel. Bioinformatics.
33. Saraswathi V, Gao L, Morrow JD, Chait A, Niswender KD, et al. (2007) Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice. J Nutr 137: 1776-1782. (Pubitemid 47037706)
34. Matsumoto M, Sata M, Fukuda D, Tanaka K, Soma M, et al. (2008) Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice. Atherosclerosis 197: 524-533. (Pubitemid 351417875)
35. Nakajima K, Yamashita T, Kita T, Takeda M, Sasaki N, et al. (2011) Orally administered eicosapentaenoic acid induces rapid regression of atherosclerosis via modulating the phenotype of dendritic cells in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 31: 1963-1972.
36. Wang S, Wu D, Matthan NR, Lamon-Fava S, Lecker JL, et al. (2009) Reduction in dietary omega-6 polyunsaturated fatty acids: eicosapentaenoic acid plus docosahexaenoic acid ratio minimizes atherosclerotic lesion formation and inflammatory response in the LDL receptor null mouse. Atherosclerosis 204: 147-155.
37. Mozaffarian D, Rimm EB (2006) Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296: 1885-1899. (Pubitemid 44596197)
38. Brossard N, Croset M, Pachiaudi C, Riou JP, Tayot JL, et al. (1996) Retroconversion and metabolism of [13C]22: 6n-3 in humans and rats after intake of a single dose of [13C]22: 6n-3-triacylglycerols. Am J Clin Nutr 64: 577-586. (Pubitemid 26334237)
39. Saito M, Ueno M, Kubo K, Yamaguchi M (1998) Dose-Response Effect of Dietary Docosahexaenoic Acid on Fatty Acid Profiles of Serum and Tissue Lipids in Rats. J Agric Food Chem 46: 184-193. (Pubitemid 128488042)
40. Adan Y, Shibata K, Sato M, Ikeda I, Imaizumi K (1999) Effects of docosahexaenoic and eicosapentaenoic acid on lipid metabolism, eicosanoid production, platelet aggregation and atherosclerosis in hypercholesterolemic rats. Biosci Biotechnol Biochem 63: 111-119. (Pubitemid 129555245)
41. Vila L (2004) Cyclooxygenase and 5-lipoxygenase pathways in the vessel wall: role in atherosclerosis. Med Res Rev 24: 399-424.
42. Ulu A, Davis BB, Tsai HJ, Kim IH, Morisseau C, et al. (2008) Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model. J Cardiovasc Pharmacol 52: 314-323.
43. Keenan AH, Pedersen TL, Fillaus K, Larson MK, Shearer GC, et al. (2012) Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to highdose n3-HUFA in healthy volunteers. J Lipid Res 53: 1662-1669.
44. Schuchardt JP, Schmidt S, Kressel G, Dong H, Willenberg I, et al. (2013) Comparison of free serum oxylipin concentrations in hyper- vs. normolipidemic men. Prostaglandins Leukot Essent Fatty Acids 89: 19-29.
45. Gertow K, Nobili E, Folkersen L, Newman JW, Pedersen TL, et al. (2011) 12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms. Atherosclerosis 215: 411-416.
46. Stephensen CB, Armstrong P, Newman JW, Pedersen TL, Legault J, et al. (2011) ALOX5 gene variants affect eicosanoid production and response to fish oil supplementation. J Lipid Res 52: 991-1003.
47. Sethi S, Eastman AY, Eaton JW (1996) Inhibition of phagocyte-endothelium interactions by oxidized fatty acids: a natural anti-inflammatory mechanism? J Lab Clin Med 128: 27-38. (Pubitemid 26369168)
48. Sethi S, Ziouzenkova O, Ni H, Wagner DD, Plutzky J, et al. (2002) Oxidized omega-3 fatty acids in fish oil inhibit leukocyte-endothelial interactions through activation of PPAR alpha. Blood 100: 1340-1346. (Pubitemid 34864290)
49. Jude S, Bedut S, Roger S, Pinault M, Champeroux P, et al. (2003) Peroxidation of docosahexaenoic acid is responsible for its effects on I TO and I SS in rat ventricular myocytes. Br J Pharmacol 139: 816-822. (Pubitemid 36819609)
50. Brooks JD, Milne GL, Yin H, Sanchez SC, Porter NA, et al. (2008) Formation of highly reactive cyclopentenone isoprostane compounds (A3/J3-isoprostanes) in vivo from eicosapentaenoic acid. J Biol Chem 283: 12043-12055.
51. Musiek ES, Brooks JD, Joo M, Brunoldi E, Porta A, et al. (2008) Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid. J Biol Chem 283: 19927-19935.
52. Brooks JD, Musiek ES, Koestner TR, Stankowski JN, Howard JR, et al. (2011) The fatty acid oxidation product 15-A3t-isoprostane is a potent inhibitor of NFkappaB transcription and macrophage transformation. J Neurochem 119: 604-616.